ProjectAnnexai

Basic data

Title:
Annexai
Duration:
7/10/2019 to 7/31/2022
Abstract / short description:
A phase d Randomized
Clinical Trial of Andexanet Alfa (Andexanet
Alfa for Injection) in Acute Intracranial
Hemorrhage in Patients Receiving an Orsl
Factsr Xa Inhibitor"

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurovascular Diseases
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

San Francisco, Kalifornien, United States of America
Help

will be deleted permanently. This cannot be undone.